Diffusion Pharmaceuticals... (DFFN)
NASDAQ: DFFN
· Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM
Diffusion Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -22.69M | -20.06M | 2.28B | 6.55B | 6.55B | 6.55B | 8.5B | 8.79B | 8.8B | 8.81B | 4.56B | 711K | 90K | -17.88M | -10.39M |
Interest Income | 3.27M | 2.91M | 1.55M | 1.08M | 573.88K | 650.92K | 526.84K | 380.75K | 199.03K | 125.03K | 124.88K | 137.49K | 146.35K | 124.88K | 95.56K |
Pretax Income | -24.2M | -17.16M | -7.03M | -6.37M | -8.13M | -13.08M | -15.16M | -15.59M | -14.99M | -24.84M | -24.42M | -24.54M | -25.13M | -17.73M | -17.58M |
Net Income | 8.33B | 8.34B | -7.03M | -8.37B | -8.36B | -8.37B | -8.37B | -15.09M | -20.59M | -24.39M | -23.98M | -24.09M | -24.68M | -16.92M | -16.27M |
Selling & General & Admin | 8.69M | 8.71M | 9.35M | 10.1M | 9.93M | 9.65M | 9.56M | 8.73M | 8.33M | 8.13M | 7.83M | 7.45M | 6.99M | 7.17M | 6.79M |
Research & Development | 29.36M | 26.31M | 10.76M | 6.94M | 5.08M | 4.08M | 6.12M | 7.24M | 6.84M | 8.15M | 8.01M | 8.5M | 9.58M | 10.61M | 10.81M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 38.05M | 35.03M | 20.11M | 17.05M | 15.01M | 13.73M | 15.68M | 15.97M | 15.19M | 16.32M | 15.91M | 16.04M | 16.66M | 17.88M | 17.7M |
Interest Expense | -8.36B | -8.36B | n/a | 8.36B | 8.36B | 8.36B | 8.36B | 124.71K | -21.29K | -146K | -146K | -146K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.2M | 21.41M | 6.5M | 10.76M | 15.01M | 13.73M | 15.68M | 15.97M | 15.19M | 16.32M | 15.91M | 16.04M | 16.66M | 17.88M | 17.7M |
Income Tax Expense | -8.36B | -8.36B | n/a | 8.36B | 8.35B | 8.36B | 8.36B | -505K | 5.6M | -444K | -444K | -444K | -444K | -806K | -1.31M |
Shares Outstanding (Basic) | 8.7M | 8.07M | 8.7M | 8.7M | 3.77M | 1.36M | 2.04M | 2.04M | 2.04M | 1.36M | 2.04M | 97.63M | 2.04M | 2.04M | 1.65M |
Shares Outstanding (Diluted) | 8.7M | 8.07M | 8.7M | 8.7M | 3.77M | 1.36M | 2.04B | 1.36M | 2.04M | 1.36M | 2.04M | 97.63M | 2.04M | 2.04M | 1.65M |
EPS (Basic) | 1.03K | 1.03K | -1.8 | -6.15K | -6.15K | -6.16K | -6.16K | -9.99 | -11.52 | -11.33 | -10.1 | -10.69 | -10.73 | -8.24 | -9.4 |
EPS (Diluted) | 1.03K | 1.03K | -1.8 | -6.15K | -6.15K | -6.16K | -6.16K | -9.99 | -11.52 | -11.33 | -10.1 | -10.69 | -10.73 | -8.24 | -11.39 |
EBITDA | -8.38B | -8.38B | -13.36M | 4.26B | 4.26B | 4.26B | 4.25B | -15.97M | -15.16M | -7.64M | -7.2M | -7.3M | -7.93M | -17.78M | -17.6M |
EBIT | -12.63B | -12.63B | n/a | 12.63B | 12.63B | 12.63B | 12.63B | 4.75M | -6.29M | -3.62M | -7.45M | -12.14M | -12.67M | -17.94M | -10.45M |
Depreciation & Amortization | -82.5K | -122.09K | 82.5K | 82.5K | 5.72M | -85.92K | -121.94K | -13.67M | -19.28M | -13.41M | -13.48M | 93.42K | 92.24K | 97.33K | 100.59K |